世界の長時間作用型インスリン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Long Acting Insulins Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4437 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、長時間作用型インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インスリングラルギン、インスリンデテミル、インスリンデグルデク、長時間作用型動物インスリン）、用途別市場規模（家庭用、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・長時間作用型インスリンの市場動向 ・企業の競争状況、市場シェア ・長時間作用型インスリンの種類別市場規模と予測2016-2027（インスリングラルギン、インスリンデテミル、インスリンデグルデク、長時間作用型動物インスリン） ・長時間作用型インスリンの用途別市場規模と予測2016-2027（家庭用、医療機関、その他） ・長時間作用型インスリンの北米市場規模2016-2027（アメリカ、カナダ） ・長時間作用型インスリンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・長時間作用型インスリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・長時間作用型インスリンの中南米市場規模2016-2027（メキシコ、ブラジル） ・長時間作用型インスリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novo Nordisk、Sanofi、Wockhardt UK） ・結論

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.

Market Analysis and Insights: Global Long Acting Insulins Market
The global Long Acting Insulins market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long Acting Insulins market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long Acting Insulins market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long Acting Insulins market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long Acting Insulins market.

Global Long Acting Insulins Scope and Market Size
Long Acting Insulins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long Acting Insulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin

Segment by Application
Home Use
Medical Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Sanofi
Wockhardt UK

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Insulin Glargine
1.2.3 Insulin Determir
1.2.4 Insulin Degludec
1.2.5 Long Acting Animal Insulin
1.3 Market by Application
1.3.1 Global Long Acting Insulins Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Long Acting Insulins Market Perspective (2016-2027)
2.2 Long Acting Insulins Growth Trends by Regions
2.2.1 Long Acting Insulins Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Long Acting Insulins Historic Market Share by Regions (2016-2021)
2.2.3 Long Acting Insulins Forecasted Market Size by Regions (2022-2027)
2.3 Long Acting Insulins Industry Dynamic
2.3.1 Long Acting Insulins Market Trends
2.3.2 Long Acting Insulins Market Drivers
2.3.3 Long Acting Insulins Market Challenges
2.3.4 Long Acting Insulins Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Long Acting Insulins Players by Revenue
3.1.1 Global Top Long Acting Insulins Players by Revenue (2016-2021)
3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2016-2021)
3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Long Acting Insulins Revenue
3.4 Global Long Acting Insulins Market Concentration Ratio
3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2020
3.5 Long Acting Insulins Key Players Head office and Area Served
3.6 Key Players Long Acting Insulins Product Solution and Service
3.7 Date of Enter into Long Acting Insulins Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Long Acting Insulins Breakdown Data by Type
4.1 Global Long Acting Insulins Historic Market Size by Type (2016-2021)
4.2 Global Long Acting Insulins Forecasted Market Size by Type (2022-2027)

5 Long Acting Insulins Breakdown Data by Application
5.1 Global Long Acting Insulins Historic Market Size by Application (2016-2021)
5.2 Global Long Acting Insulins Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Long Acting Insulins Market Size (2016-2027)
6.2 North America Long Acting Insulins Market Size by Type
6.2.1 North America Long Acting Insulins Market Size by Type (2016-2021)
6.2.2 North America Long Acting Insulins Market Size by Type (2022-2027)
6.2.3 North America Long Acting Insulins Market Size by Type (2016-2027)
6.3 North America Long Acting Insulins Market Size by Application
6.3.1 North America Long Acting Insulins Market Size by Application (2016-2021)
6.3.2 North America Long Acting Insulins Market Size by Application (2022-2027)
6.3.3 North America Long Acting Insulins Market Size by Application (2016-2027)
6.4 North America Long Acting Insulins Market Size by Country
6.4.1 North America Long Acting Insulins Market Size by Country (2016-2021)
6.4.2 North America Long Acting Insulins Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Long Acting Insulins Market Size (2016-2027)
7.2 Europe Long Acting Insulins Market Size by Type
7.2.1 Europe Long Acting Insulins Market Size by Type (2016-2021)
7.2.2 Europe Long Acting Insulins Market Size by Type (2022-2027)
7.2.3 Europe Long Acting Insulins Market Size by Type (2016-2027)
7.3 Europe Long Acting Insulins Market Size by Application
7.3.1 Europe Long Acting Insulins Market Size by Application (2016-2021)
7.3.2 Europe Long Acting Insulins Market Size by Application (2022-2027)
7.3.3 Europe Long Acting Insulins Market Size by Application (2016-2027)
7.4 Europe Long Acting Insulins Market Size by Country
7.4.1 Europe Long Acting Insulins Market Size by Country (2016-2021)
7.4.2 Europe Long Acting Insulins Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Long Acting Insulins Market Size (2016-2027)
8.2 Asia-Pacific Long Acting Insulins Market Size by Type
8.2.1 Asia-Pacific Long Acting Insulins Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Long Acting Insulins Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Long Acting Insulins Market Size by Type (2016-2027)
8.3 Asia-Pacific Long Acting Insulins Market Size by Application
8.3.1 Asia-Pacific Long Acting Insulins Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Long Acting Insulins Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Long Acting Insulins Market Size by Application (2016-2027)
8.4 Asia-Pacific Long Acting Insulins Market Size by Region
8.4.1 Asia-Pacific Long Acting Insulins Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Long Acting Insulins Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Long Acting Insulins Market Size (2016-2027)
9.2 Latin America Long Acting Insulins Market Size by Type
9.2.1 Latin America Long Acting Insulins Market Size by Type (2016-2021)
9.2.2 Latin America Long Acting Insulins Market Size by Type (2022-2027)
9.2.3 Latin America Long Acting Insulins Market Size by Type (2016-2027)
9.3 Latin America Long Acting Insulins Market Size by Application
9.3.1 Latin America Long Acting Insulins Market Size by Application (2016-2021)
9.3.2 Latin America Long Acting Insulins Market Size by Application (2022-2027)
9.3.3 Latin America Long Acting Insulins Market Size by Application (2016-2027)
9.4 Latin America Long Acting Insulins Market Size by Country
9.4.1 Latin America Long Acting Insulins Market Size by Country (2016-2021)
9.4.2 Latin America Long Acting Insulins Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Long Acting Insulins Market Size (2016-2027)
10.2 Middle East & Africa Long Acting Insulins Market Size by Type
10.2.1 Middle East & Africa Long Acting Insulins Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Long Acting Insulins Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Long Acting Insulins Market Size by Type (2016-2027)
10.3 Middle East & Africa Long Acting Insulins Market Size by Application
10.3.1 Middle East & Africa Long Acting Insulins Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Long Acting Insulins Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Long Acting Insulins Market Size by Application (2016-2027)
10.4 Middle East & Africa Long Acting Insulins Market Size by Country
10.4.1 Middle East & Africa Long Acting Insulins Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Long Acting Insulins Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Long Acting Insulins Introduction
11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Long Acting Insulins Introduction
11.2.4 Sanofi Revenue in Long Acting Insulins Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Wockhardt UK
11.3.1 Wockhardt UK Company Details
11.3.2 Wockhardt UK Business Overview
11.3.3 Wockhardt UK Long Acting Insulins Introduction
11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2016-2021)
11.3.5 Wockhardt UK Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Insulin Glargine
Table 3. Key Players of Insulin Determir
Table 4. Key Players of Insulin Degludec
Table 5. Key Players of Long Acting Animal Insulin
Table 6. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Long Acting Insulins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Long Acting Insulins Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Long Acting Insulins Market Share by Regions (2016-2021)
Table 10. Global Long Acting Insulins Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Long Acting Insulins Market Share by Regions (2022-2027)
Table 12. Long Acting Insulins Market Trends
Table 13. Long Acting Insulins Market Drivers
Table 14. Long Acting Insulins Market Challenges
Table 15. Long Acting Insulins Market Restraints
Table 16. Global Long Acting Insulins Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Long Acting Insulins Market Share by Players (2016-2021)
Table 18. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2020)
Table 19. Ranking of Global Top Long Acting Insulins Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Long Acting Insulins Product Solution and Service
Table 23. Date of Enter into Long Acting Insulins Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Long Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Long Acting Insulins Revenue Market Share by Type (2016-2021)
Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Long Acting Insulins Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Long Acting Insulins Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Long Acting Insulins Revenue Market Share by Application (2016-2021)
Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Long Acting Insulins Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Long Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Long Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Long Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Long Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Long Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Long Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Long Acting Insulins Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Long Acting Insulins Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Long Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Long Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Long Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Long Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novo Nordisk Company Details
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Long Acting Insulins Product
Table 66. Novo Nordisk Revenue in Long Acting Insulins Business (2016-2021) & (US$ Million)
Table 67. Novo Nordisk Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Long Acting Insulins Product
Table 71. Sanofi Revenue in Long Acting Insulins Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Wockhardt UK Company Details
Table 74. Wockhardt UK Business Overview
Table 75. Wockhardt UK Long Acting Insulins Product
Table 76. Wockhardt UK Revenue in Long Acting Insulins Business (2016-2021) & (US$ Million)
Table 77. Wockhardt UK Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Insulins Market Share by Type: 2020 VS 2027
Figure 2. Insulin Glargine Features
Figure 3. Insulin Determir Features
Figure 4. Insulin Degludec Features
Figure 5. Long Acting Animal Insulin Features
Figure 6. Global Long Acting Insulins Market Share by Application: 2020 VS 2027
Figure 7. Home Use Case Studies
Figure 8. Medical Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. Long Acting Insulins Report Years Considered
Figure 11. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Long Acting Insulins Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Long Acting Insulins Market Share by Regions: 2020 VS 2027
Figure 14. Global Long Acting Insulins Market Share by Regions (2022-2027)
Figure 15. Global Long Acting Insulins Market Share by Players in 2020
Figure 16. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2020
Figure 18. Global Long Acting Insulins Revenue Market Share by Type (2016-2021)
Figure 19. Global Long Acting Insulins Revenue Market Share by Type (2022-2027)
Figure 20. North America Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Long Acting Insulins Market Share by Type (2016-2027)
Figure 22. North America Long Acting Insulins Market Share by Application (2016-2027)
Figure 23. North America Long Acting Insulins Market Share by Country (2016-2027)
Figure 24. United States Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Long Acting Insulins Market Share by Type (2016-2027)
Figure 28. Europe Long Acting Insulins Market Share by Application (2016-2027)
Figure 29. Europe Long Acting Insulins Market Share by Country (2016-2027)
Figure 30. Germany Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Long Acting Insulins Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Long Acting Insulins Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Long Acting Insulins Market Share by Region (2016-2027)
Figure 40. China Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Long Acting Insulins Market Share by Type (2016-2027)
Figure 48. Latin America Long Acting Insulins Market Share by Application (2016-2027)
Figure 49. Latin America Long Acting Insulins Market Share by Country (2016-2027)
Figure 50. Mexico Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Long Acting Insulins Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Long Acting Insulins Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Long Acting Insulins Market Share by Country (2016-2027)
Figure 56. Turkey Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2016-2021)
Figure 61. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---